$BIVI
BIOVIE INC. Stock $bivi

$bivi Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000152013823000325 Filed on August 16, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.943M	$2.620M	$11.55M
YoY Change	-3.2%	-22.08%	18.29%
% of Gross Profit
Research & Development	$8.876M	$8.300M	$33.30M
YoY Change	31.1%	41.33%	92.95%
% of Gross Profit
Depreciation & Amortization	$60.00K	$57.35K	$229.4K
YoY Change	4.64%	0.0%	0.0%
% of Gross Profit
Operating Expenses	$10.88M	$10.98M	$45.08M
YoY Change	23.11%	18.13%	65.41%
Operating Profit	-$10.88M		-$45.08M
YoY Change	23.11%		65.41%
Interest Expense	$1.005M	$1.865M	$4.300M
YoY Change	-4.9%	55.01%	98.81%
% of Operating Profit
Other Income/Expense, Net	$165.4K		-$5.175M
YoY Change
Pretax Income	-$10.71M	-$9.112M	-$50.26M
YoY Change	2.83%	12.65%	92.68%
Income Tax
% Of Pretax Income
Net Earnings	-$10.71M	-$9.112M	-$50.26M
YoY Change	2.83%	12.65%	92.67%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.29		-$1.55
Diluted Earnings Per Share	-$0.29	-$0.25	-$1.55
COMMON SHARES
Basic Shares Outstanding	36.80M shares	36.28M shares	32.48M shares
Diluted Shares Outstanding	36.74M shares		32.48M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.21M	$33.94M	$33.94M
YoY Change	-0.1%	82.06%	82.06%
Cash & Equivalents	$21.21M	$19.46M
Short-Term Investments	$0.00	$14.48M	$14.48M
Other Short-Term Assets	$1.550M	$102.5K	$102.5K
YoY Change	331.61%	-25.64%	-25.64%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$22.76M	$34.04M	$34.04M
YoY Change	5.44%	81.27%	81.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$70.00K	$80.79K	$80.79K
YoY Change	-35.94%	-31.68%	-31.68%
Goodwill	$345.7K	$345.7K
YoY Change	0.0%	0.0%
Intangibles	$579.8K	$637.1K
YoY Change	-28.35%	-26.47%
Long-Term Investments
YoY Change
Other Assets			$0.00
YoY Change			-100.0%
Total Long-Term Assets	$996.2K	$1.064M	$1.064M
YoY Change	-21.48%	-20.33%	-20.33%
TOTAL ASSETS
Total Short-Term Assets	$22.76M	$34.04M	$34.04M
Total Long-Term Assets	$996.2K	$1.064M	$1.064M
Total Assets	$23.76M	$35.10M	$35.10M
YoY Change	3.94%	74.52%	74.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.715M	$3.476M	$3.476M
YoY Change	3.52%	42.31%	42.31%
Accrued Expenses	$50.00K	$44.91K	$44.91K
YoY Change	24.01%	15.51%	15.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.340M	$9.105M	$9.105M
YoY Change
Total Short-Term Liabilities	$13.21M	$14.49M	$14.49M
YoY Change	222.59%	247.66%	247.66%
LONG-TERM LIABILITIES
Long-Term Debt	$2.970M	$5.227M	$5.227M
YoY Change	-76.66%	-56.94%	-56.94%
Other Long-Term Liabilities	$30.00K		$42.51K
YoY Change			-68.7%
Total Long-Term Liabilities	$3.000M	$0.00	$5.270M
YoY Change		-100.0%	-57.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.21M	$14.49M	$14.49M
Total Long-Term Liabilities	$3.000M	$0.00	$5.270M
Total Liabilities	$16.21M	$19.76M	$19.76M
YoY Change	-4.06%	20.19%	20.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$311.9M	-$301.2M
YoY Change	19.34%	20.02%
Common Stock	$319.5M	$316.4M
YoY Change	19.5%	24.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.00	$2.00
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.548M	$15.34M	$15.34M
YoY Change
Total Liabilities & Shareholders Equity	$23.76M	$35.10M	$35.10M
YoY Change	3.94%	74.52%	74.52%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$10.71M	-$9.112M	-$50.26M
YoY Change	2.83%	12.65%	92.67%
Depreciation, Depletion And Amortization	$60.00K	$57.35K	$229.4K
YoY Change	4.64%	0.0%	0.0%
Cash From Operating Activities	-$12.18M	-$11.29M	-$40.25M
YoY Change	32.07%	92.45%	111.96%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$14.53M	-$1.796M	-$14.30M
YoY Change
Cash From Investing Activities	$14.53M	-$1.796M	-$14.30M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$49.47M
YoY Change			167.22%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$594.2K	1.268M	$55.37M
YoY Change	-105.03%		67.18%
NET CHANGE
Cash From Operating Activities	-$12.18M	-11.29M	-$40.25M
Cash From Investing Activities	$14.53M	-1.796M	-$14.30M
Cash From Financing Activities	-$594.2K	1.268M	$55.37M
Net Change In Cash	$1.754M	-11.82M	$819.2K
YoY Change	-32.27%	101.45%	-94.2%
FREE CASH FLOW
Cash From Operating Activities	-$12.18M	-$11.29M	-$40.25M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001580149
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2022	bivi	Unrealized Gain On Investments For Availableforsale UnrealizedGainOnInvestmentsForAvailableforsale		usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax		usd
CY2023	bivi	Cashless Exercise Of Options CashlessExerciseOfOptions		usd
CY2023	bivi	Cashless Exercise Of Warrants CashlessExerciseOfWarrants		usd
CY2022	bivi	Stock Based Compensation Expense Stock Issued StockBasedCompensationExpenseStockIssued		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2022	bivi	Purchases Of U.S.Treasury Bills PurchasesOfU.s.TreasuryBills		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022	bivi	Net Proceeds From Issuance Of Common Stock Related Party NetProceedsFromIssuanceOfCommonStockRelatedParty		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2022	bivi	Unrealized Gain On U.S.Treasury Bill UnrealizedGainOnU.s.TreasuryBill		usd
CY2022Q2	bivi	Notes Payable Noncurrent NotesPayableNoncurrent		usd
CY2022Q2	bivi	Longterm Debt Financing Costs LongtermDebtFinancingCosts		usd
CY2022Q2	bivi	Long Term Deferred Discounts Finance Charges And Interest Included In Receivables LongTermDeferredDiscountsFinanceChargesAndInterestIncludedInReceivables		usd
CY2022Q2	bivi	Long Term Accretion Of Loan Premiums LongTermAccretionOfLoanPremiums		usd
CY2022Q2	bivi	Long Term Notes Payable Net Of Financing Costs Unearned Premiums And Discount LongTermNotesPayableNetOfFinancingCostsUnearnedPremiumsAndDiscount		usd
CY2022Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment		usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39015
CY2023	dei	Entity Registrant Name EntityRegistrantName	BIOVIE INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2510769
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	680 W Nye Lane Suite 204
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Carson City
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89703
CY2023	dei	City Area Code CityAreaCode	775
CY2023	dei	Local Phone Number LocalPhoneNumber	888-3162
CY2023	dei	Security12b Title Security12bTitle	Class A Common Stock, $.0001 par value per share
CY2023	dei	Trading Symbol TradingSymbol	BIVI
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	86033369	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36803768	shares
CY2023	dei	Auditor Name AuditorName	EisnerAmper LLP
CY2023	dei	Auditor Firm AuditorFirmId	274
CY2023	dei	Auditor Location AuditorLocation	Iselin, New Jersey
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19460883	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18641716	usd
CY2023Q2	bivi	Investments In U.S.Treasury Bills InvestmentsInU.s.TreasuryBills	14477726	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	102526	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	137879	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	34041135	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	18779595	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	80789	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118254	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	637095	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	866472	usd
CY2023Q2	us-gaap	Goodwill Goodwill	345711	usd
CY2022Q2	us-gaap	Goodwill Goodwill	345711	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4562	usd
CY2023Q2	us-gaap	Assets Assets	35104730	usd
CY2022Q2	us-gaap	Assets Assets	20114594	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3476259	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2442804	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	48385	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1304925	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44909	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38884	usd
CY2023Q2	bivi	Unearned Premium Anddiscount Current UnearnedPremiumAnddiscountCurrent	894926	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	9105074	usd
CY2023Q2	bivi	Warrant Liabilities WarrantLiabilities	894280	usd
CY2022Q2	bivi	Warrant Liabilities WarrantLiabilities	194531	usd
CY2023Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	925762	usd
CY2022Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	188030	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14494669	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4169174	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	48385	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	42505	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87414	usd
CY2023Q2	bivi	Unearned Premium And Discount UnearnedPremiumAndDiscount	227268	usd
CY2022Q2	bivi	Unearned Premium And Discount UnearnedPremiumAndDiscount	2861314	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	5227270	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	12138686	usd
CY2023Q2	us-gaap	Liabilities Liabilities	19764444	usd
CY2022Q2	us-gaap	Liabilities Liabilities	16443659	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36451829	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36428949	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24984083	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24984083	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	3643	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	2496	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	316385759	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	254638329	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	176591	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-301225705	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-250969890	usd
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15340286	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3670935	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35104730	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20114594	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	229377	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	229377	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33299503	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17258341	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11551568	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9765259	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	45080448	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	27252977	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-45080448	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-27252977	usd
CY2023	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-1437481	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	3287418	usd
CY2023	us-gaap	Interest Expense InterestExpense	4300150	usd
CY2022	us-gaap	Interest Expense InterestExpense	2162989	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	562264	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	44080	usd
CY2023	bivi	Total Other Expense Income TotalOtherExpenseIncome	5175367	usd
CY2022	bivi	Total Other Expense Income TotalOtherExpenseIncome	-1168509	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-50255815	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-26084468	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-50255815	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-26084468	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.55
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.55
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32483489	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24662557	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32483489	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24662557	shares
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-50255815	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26084468	usd
CY2023	bivi	Unrealized Gain On Investments For Availableforsale UnrealizedGainOnInvestmentsForAvailableforsale	176591	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	176591	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-50079224	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26084468	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	5050315	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5807871	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18511009	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	386208	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-26084468	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3670935	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4222845	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1780047	usd
CY2023	bivi	Stockbased Compensation Issuance Of Common Stock StockbasedCompensationIssuanceOfCommonStock	372500	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2240	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	49465103	usd
CY2023	bivi	Proceeds From Issuance Of Common Stock Net Of Costs Of94160 Related Party ProceedsFromIssuanceOfCommonStockNetOfCostsOf94160RelatedParty	5905840	usd
CY2023	bivi	Unrealized Gain On Availableforsale Securities UnrealizedGainOnAvailableforsaleSecurities	176591	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-50255815	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15340286	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-50255815	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-26084468	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	229377	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	229377	usd
CY2023	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	1780047	usd
CY2022	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	386208	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	4222845	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	5807871	usd
CY2023	bivi	Stock Based Compensation Expense Stock Issued StockBasedCompensationExpenseStockIssued	372500	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	170219	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	99295	usd
CY2023	bivi	Interest Expense From Convertible Debenture InterestExpenseFromConvertibleDebenture	-1601445	usd
CY2022	bivi	Interest Expense From Convertible Debenture InterestExpenseFromConvertibleDebenture	-934177	usd
CY2023	bivi	Accretion Of Loan Premium AccretionOfLoanPremium	421994	usd
CY2022	bivi	Accretion Of Loan Premium AccretionOfLoanPremium	165278	usd
CY2023	bivi	Change In Operating Lease Rightofuse Assets ChangeInOperatingLeaseRightofuseAssets	37465	usd
CY2022	bivi	Change In Operating Lease Rightofuse Assets ChangeInOperatingLeaseRightofuseAssets	8044	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1437481	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3287418	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-39915	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	48954	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1033455	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1446430	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-38884	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1304925	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1353310	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40252881	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18990850	usd
CY2023	bivi	Purchases Of U.S.Treasury Bills PurchasesOfU.s.TreasuryBills	14301135	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14301135	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49465103	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18511009	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	14609915	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2240	usd
CY2023	bivi	Net Proceeds From Issuance Of Common Stock Related Party NetProceedsFromIssuanceOfCommonStockRelatedParty	5905840	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	55373183	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33120924	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	819167	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	14130074	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18641716	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4511642	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19460883	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18641716	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	2106491	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	964241	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	130039	usd
CY2023	bivi	Unrealized Gain On U.S.Treasury Bill UnrealizedGainOnU.s.TreasuryBill	176591	usd
CY2023Q2	bivi	Working Capital WorkingCapital	19500000	usd
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	33900000	usd
CY2023Q2	bivi	Stockholder Equities StockholderEquities	15300000	usd
CY2023Q2	bivi	Accumulated Deficit AccumulatedDeficit	301000000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zrQnqt0hkpdc" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances. The amounts of assets and liabilities reported in the Companys balance sheet and the amounts of expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but not limited to, accounting for clinical accruals, share-based compensation, accounting for derivatives, assumptions used in leases and recoverability of intangible assets, the inputs used in the valuation of goodwill and intangible assets in connection with impairment testing and accounting for income taxes. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	bivi	Unearned Discount UnearnedDiscount	1600000	usd
CY2023	bivi	Accretions Of Loan Premium AccretionsOfLoanPremium	422000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	2200000	usd
CY2022	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	952000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	99000	usd
CY2022	bivi	Accretions Of Loan Premium AccretionsOfLoanPremium	165000	usd
CY2023Q2	bivi	Notes Payable Noncurrent NotesPayableNoncurrent	10000000	usd
CY2023Q2	bivi	Longterm Debt Financing Costs LongtermDebtFinancingCosts	-108751	usd
CY2023Q2	bivi	Long Term Deferred Discounts Finance Charges And Interest Included In Receivables LongTermDeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	-1023145	usd
CY2023	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12319606	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4033656	shares
CY2023Q2	bivi	Long Term Accretion Of Loan Premiums LongTermAccretionOfLoanPremiums	236970	usd
CY2023Q2	bivi	Long Term Notes Payable Net Of Financing Costs Unearned Premiums And Discount LongTermNotesPayableNetOfFinancingCostsUnearnedPremiumsAndDiscount	9105074	usd
CY2023Q2	bivi	Current Portion Of Notes Payable CurrentPortionOfNotesPayable	5000000	usd
CY2022Q2	bivi	Current Portion Of Notes Payable CurrentPortionOfNotesPayable	15000000	usd
CY2023Q2	bivi	Debt Financing Costs DebtFinancingCosts	-11820	usd
CY2022Q2	bivi	Debt Financing Costs DebtFinancingCosts	-290790	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023Q2	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	111212	usd
CY2022Q2	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	2735802	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2293770	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2293770	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1656675	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1427298	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	637095	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	866472	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	229377	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	229377	usd
CY2023Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	229377	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	229377	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	178341	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	637095	usd
CY2023Q2	us-gaap	Other Liabilities OtherLiabilities	48400	usd
CY2022Q2	us-gaap	Other Liabilities OtherLiabilities	1300000	usd
CY2023Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	48400	usd
CY2022Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	580614	usd
CY2021Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1161000	usd
CY2023	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0825	pure
CY2023	bivi	Direct Financing Cost DirectFinancingCost	390000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	850000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	4300000	usd
CY2023	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	2100000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	170000	usd
CY2023Q2	bivi	Accretion Of Loan Premiums AccretionOfLoanPremiums	350302	usd
CY2022Q2	bivi	Accretion Of Loan Premiums AccretionOfLoanPremiums	165278	usd
CY2023Q2	bivi	Notes Payable Net Of Current Portion Financing Costs Unearned Premiums And Discount NotesPayableNetOfCurrentPortionFinancingCostsUnearnedPremiumsAndDiscount	5227270	usd
CY2022Q2	bivi	Notes Payable Net Of Current Portion Financing Costs Unearned Premiums And Discount NotesPayableNetOfCurrentPortionFinancingCostsUnearnedPremiumsAndDiscount	12138686	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1820042	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	382561	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	33938609	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	18641716	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.8165	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.7647	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0382	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0156	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3952864	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1473413	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2592000	shares
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18500000	usd
CY2021Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2200000	usd
CY2022Q4	bivi	Total Compensation Cost TotalCompensationCost	1744192	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44909	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	52000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	89000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	80789	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118254	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44909	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38884	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	42505	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87414	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	87414	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	126298	usd
CY2023	bivi	Schedule Of Future Estimated Minimum Lease Payments Under Non Cancelable Operating Leases ScheduleOfFutureEstimatedMinimumLeasePaymentsUnderNonCancelableOperatingLeases	<table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfFutureEstimatedMinimumLeasePaymentsUnderNonCancelableOperatingLeases_z9LZTskl75Ld" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span id="xdx_8BC_ztjTSxsT8KRf" style="display: none">Schedule of future estimated minimum lease payments under non-cancelable operating leases</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49F_20230630_zy3WERKxcCbj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ending June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,156</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,636</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_zsbHcL5y4K7b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total minimum lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,792</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zs9re4OhbjH4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less amount representing interest</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,378</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_ecustom--PresentValueOfFutureMinimumLeasePayments_iI_pp0p0_zfva7N61F7Ga" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of future minimum lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pp0p0_di_zWAbagOxVLrj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less current portion of operating lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(44,909</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_404_ecustom--OperatingLeaseLiabilitiesNetOfCurrentPortion_iI_pp0p0_ztGsQXmuYDme" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 3.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liabilities, net of current portion</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 3.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 3.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,505</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table>
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	52156	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	44636	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	96792	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9378	usd
CY2023Q2	bivi	Present Value Of Future Minimum Lease Payments PresentValueOfFutureMinimumLeasePayments	87414	usd
CY2023Q2	bivi	Operating Lease Liabilities Net Of Current Portion OperatingLeaseLiabilitiesNetOfCurrentPortion	42505	usd
CY2023	bivi	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	50600	usd
CY2022	bivi	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	4175	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1075	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1075	pure
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	171900	usd
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	121000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	4018817	usd
CY2022Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6410653	usd
CY2023Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-189854	usd
CY2022Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-258209	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1788862	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1845836	usd
CY2023Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	7938602	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13556427	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7998280	usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	13600000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	8000000.0	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5600000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6000000.0	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	168000000	usd
CY2023	bivi	Expirations Dates ExpirationsDates	2032 to 2037
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.09	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.09	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.30	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.30	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure

Files In Submission

Name	View Source	Status
0001520138-23-000325-index-headers.html	Edgar Link	pending
0001520138-23-000325-index.html	Edgar Link	pending
0001520138-23-000325.txt	Edgar Link	pending
0001520138-23-000325-xbrl.zip	Edgar Link	pending
bivi-20230630.xsd	Edgar Link	pending
bivi-20230630_10k.htm	Edgar Link	pending
bivi-20230630_10kex23z1.htm	Edgar Link	pending
bivi-20230630_10kex31z1.htm	Edgar Link	pending
bivi-20230630_10kex31z2.htm	Edgar Link	pending
bivi-20230630_10kex32z1.htm	Edgar Link	pending
bivi-20230630_10kex32z2.htm	Edgar Link	pending
bivi-20230630_cal.xml	Edgar Link	unprocessable
bivi-20230630_10k_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
bivi-20230630_lab.xml	Edgar Link	unprocessable
bivi-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bivi-20230630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIVI
BIOVIE INC. Stock $bivi

2023 Q3 Form 10-K Financial Statement

#000152013823000325 Filed on August 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIVI BIOVIE INC. Stock $bivi

2023 Q3 Form 10-K Financial Statement

#000152013823000325 Filed on August 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIVI
BIOVIE INC. Stock $bivi